Ashford Capital Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-98,870
| Closed | -$482K | – | 93 |
|
|
2022
Q4 | $482K | Sell |
98,870
-3,100
| -3% | -$15.1K | 0.07% | 74 |
|
|
2022
Q3 | $1.47M | Sell |
101,970
-2,230
| -2% | -$32.1K | 0.22% | 54 |
|
|
2022
Q2 | $1.58M | Sell |
104,200
-2,570
| -2% | -$38.9K | 0.22% | 57 |
|
|
2022
Q1 | $1.27M | Sell |
106,770
-119,410
| -53% | -$1.42M | 0.14% | 74 |
|
|
2021
Q4 | $3.67M | Sell |
226,180
-225,930
| -50% | -$3.66M | 0.37% | 50 |
|
|
2021
Q3 | $12.9M | Sell |
452,110
-131,398
| -23% | -$3.75M | 1.17% | 35 |
|
|
2021
Q2 | $19.7M | Buy |
583,508
+75,425
| +15% | +$2.55M | 1.78% | 30 |
|
|
2021
Q1 | $15.4M | Buy |
508,083
+288,664
| +132% | +$8.73M | 1.44% | 34 |
|
|
2020
Q4 | $10.9M | Buy |
+219,419
| New | +$10.9M | 1.05% | 34 |
|